首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   359篇
  免费   39篇
  国内免费   22篇
妇产科学   1篇
基础医学   29篇
口腔科学   1篇
临床医学   40篇
内科学   34篇
皮肤病学   3篇
神经病学   16篇
特种医学   13篇
外科学   38篇
综合类   88篇
预防医学   7篇
眼科学   6篇
药学   44篇
中国医学   87篇
肿瘤学   13篇
  2024年   2篇
  2023年   21篇
  2022年   45篇
  2021年   36篇
  2020年   36篇
  2019年   21篇
  2018年   15篇
  2017年   13篇
  2016年   11篇
  2015年   22篇
  2014年   37篇
  2013年   22篇
  2012年   37篇
  2011年   33篇
  2010年   25篇
  2009年   13篇
  2008年   6篇
  2007年   6篇
  2006年   6篇
  2005年   1篇
  2004年   1篇
  2002年   1篇
  1999年   1篇
  1998年   2篇
  1997年   1篇
  1996年   2篇
  1994年   1篇
  1993年   1篇
  1990年   1篇
  1988年   1篇
排序方式: 共有420条查询结果,搜索用时 31 毫秒
1.
Abstract

The autoimmune condition Hashimoto’s thyroiditis (HT) is a disease wherein lymphocytes mediate the autoimmune damage and destruction of the thyroid gland. There are currently no effective means of treating HT, with the primary strategies of thyroid hormone therapy, surgery, or immunomodulatory therapy being associated with serious risks and side effects. There is thus a clear and urgent need to identify novel treatments for HT. In this study, we utilize female SD rats induced HT to evaluated the ability of transplanted MSCs to regulate Th17/Treg interactions in a rat Hashimoto’s thyroiditis (HT) model system. The results showed that Rats in the HT model group exhibited increased thyroid autoantibody levels consistent with successful model development, whereas these levels were lower in rats treated with MSCs. There were also fewer thyroid lesions and less lymphoid infiltration of the thyroid in MSC-treated rats relative to HT model rats, as well as fewer Th17 cells and more Treg cells – an observation consistent with the cytokine analyses. All of these showed that MSCs can regulate Th17/Treg interactions in a rat Hashimoto’s thyroiditis (HT) model system. It suggested that transplanted MSCs could be a potential immunotherapy strategy for the treatment of Hashimoto’s thyroiditis.  相似文献   
2.
  目的  探究在长期临床等效剂量下4种清热燥湿类中药对正常小鼠肠道菌群、胆汁酸及短链脂肪酸的影响。  方法  30只Balb/c雄性小鼠被随机分为对照组、苦参组、黄连组、黄柏组和黄芩组, 每组各6只。除对照组外, 苦参组、黄柏组、黄连组和黄芩组给药剂量分别为2.34、3.12、1.3 g·kg-1和2.6 g·kg-1, 连续灌胃2周, 采用液相色谱-串联质谱法检测粪便中短链脂肪酸和胆汁酸含量, 利用16S rRNA高通量基因测序技术分析肠道内容物中菌群结构变化。  结果  清热燥湿类中药对正常小鼠粪便中6种短链脂肪酸无明显影响。在常见的23种胆汁酸中, 与正常组相比, 黄芩组、苦参组、黄连组和黄柏组分别有4、3、2、1种胆汁酸显著变化。从肠道菌群丰度变化上看, 与对照组相比, 除苦参组外, 黄连组、黄芩组和黄柏组小鼠厚壁菌门均呈现下降趋势, 拟杆菌门均呈现上升趋势, 其中黄连组变化更显著。  结论  苦参、黄柏、黄连和黄芩对正常小鼠长期药效剂量下短链脂肪酸影响较小, 但可以通过改变肠道菌群结构影响胆汁酸含量的变化。   相似文献   
3.
张敏 《中国卫生产业》2021,(2):44-46,82
在卫生事业的发展过程中,应该注重人才队伍的建设,强化人才队伍建设的创新改革力度,转变传统的人才管理工作思维与模式,遵循健康发展、协调发展的基本原则,借助人才队伍的建设促使卫生事业良好发展和进步,形成新时期背景下的卫生事业发展动力,彰显人才队伍的积极作用。该文就当前卫生事业人才队伍的现状,提出加强人才队伍建设促进卫生事业发展的指导思想,并且归纳总结卫生事业发展过程中人才队伍的建设经验、对策,争取可以采用有效的措施建设人才队伍,提升卫生事业发展过程中的核心力量,增强服务工作效果,满足当前的时代发展需求,达到预期的工作目的。  相似文献   
4.
 目的 评估新型标志物PEG-344在高毒力肺炎克雷伯菌以及经典肺炎克雷伯菌毒力鉴别中的应用价值。方法 收集2020—2021年某院血流感染患者血标本分离的肺炎克雷伯菌,采用大蜡螟毒力试验结果作为金标准进行分组,将菌株分为高毒力组和经典组;进一步进行黏液丝试验、wzi基因测序和毒力基因检测p(rmpA、prmpA2、PEG-1631、PEG-589、PEG-344)。结果 共收集肺炎克雷伯菌36株,根据大蜡螟毒力试验结果将其分为高毒力组16株,经典组20株;高毒力组黏液丝阳性菌株占87.50%(14株),经典组黏液丝阳性菌株占15.00%(3株);毒力基因PEG-344检测的灵敏度、特异度高于经典的独立标志物prmpA、prmpA2。除1株经典组wxwh3(wzi-2)菌株PEG-344阳性以外,其余菌株PEG-344结果与毒力分组完全一致。结论 内膜转运蛋白编码基因PEG-344能更准确地鉴别高毒力菌株,及时提醒临床合理用药,为临床医生优化诊疗方案提供依据。  相似文献   
5.
6.
BackgroundPulmonary metastasectomy when possible has become therapeutic standard in soft tissue sarcoma patients. However, published reports frequently describe mixed series of patients with bone or soft tissue sarcoma. We report the outcome of 46 soft tissue sarcoma (STS) patients who underwent pulmonary metastasectomy (PM).MethodsThis current analysis includes retrospective survival data from 46 consecutive STS patients with pulmonary metastases who underwent PM at the Medical University of Vienna between January 2003 and December 2013.ResultsIn total 72 pulmonary metastasectomies were performed. 322 metastatic nodules were resected with a median number of four nodules per intervention and the R0 resection rate was 97.2%. The postoperative complication rate as documented was low. Median follow-up (mFU) was 31.8 months (range 3.7–127.4). Median overall survival as calculated from first detection of metastatic disease was 47.1 months (95% confidence interval (CI) = 36.2–58.1 months) and 45.3 months (95% CI = 33.3–57.4 months) when calculated from first PM until death or last follow-up (n = 46). Five-year overall survival calculated from primary diagnosis was 62% and 32% when estimated from first PM. Previous disease free interval (DFI) as calculated from date of surgery of the primary tumour until the date of diagnosis of lung metastasis was 12.2 months (range 0–140.1 months). Median relapse-free survival (mRFS) after first PM to the date of recurrence of lung metastasis, death or last follow-up was 13.4 months (95% CI = 3–23.8 months).ConclusionMedian overall survival in this selected patient cohort is 45.3 months. Despite the lack of prospective randomised controlled trials, PM is a reasonable treatment strategy in selected patients.  相似文献   
7.
8.
本文从张仲景《伤寒杂病论》论治水气病入手,对其进行归纳、整理和分析,初步探讨其辨证论治水气病规律。张仲景在《内经》“开鬼门,洁净腑”基础上,提出了“诸有水者,腰以下肿,当利小便;腰以上肿,当发汗乃愈”,“有水,可下之”之治疗大法。张仲景论治水气病理、法、方、药千余年来沿用至今,为后世的水肿以阴阳为纲的分类以及从肺、脾、肾论治奠定了基础,同时也为水肿的辨治拓宽了思路。  相似文献   
9.
BackgroundIncreasing prevalence of overweight and obesity represents a global pandemic. As the largest occupational group in international healthcare systems nurses are at the forefront of health promotion to address this pandemic. However, nurses own health behaviours are known to influence the extent to which they engage in health promotion and the public's confidence in advice offered. Estimating the prevalence of overweight and obesity among nurses is therefore important. However, to date, prevalence estimates have been based on non-representative samples and internationally no studies have compared prevalence of overweight and obesity among nurses to other healthcare professionals using representative data.ObjectivesTo estimate overweight and obesity prevalence among nurses in Scotland, and compare to other healthcare professionals and those working in non-heath related occupations.DesignCross-sectional study using a nationally representative sample of five aggregated annual rounds (2008–2012) of the Scottish Health Survey.SettingScotland.Participants13,483 adults aged 17–65 indicating they had worked in the past 4 weeks, classified in four occupational groups: nurses (n = 411), other healthcare professionals (n = 320), unqualified care staff (n = 685), and individuals employed in non-health related occupations (n = 12,067).Main outcome measuresPrevalence of overweight and obesity defined as Body Mass Index  25.0.MethodsEstimates of overweight and obesity prevalence in each occupational group were calculated with 95% confidence intervals (CI). A logistic regression model was then built to compare the odds of being overweight or obese with not being overweight or obese for nurses in comparison to the other occupational categories. Data were analysed using SAS 9.1.3.Results69.1% (95% CI 64.6, 73.6) of Scottish nurses were overweight or obese. Prevalence of overweight and obesity was higher in nurses than other healthcare professionals (51.3%, CI 45.8, 56.7), unqualified care staff (68.5%, CI 65.0, 72.0) and those in non-health related occupations (68.9%, CI 68.1, 69.7). A logistic regression model adjusted for socio-demographic composition indicated that, compared to nurses, the odds of being overweight or obese was statistically significantly lower for other healthcare professionals (Odds Ratio [OR] 0.45, CI 0.33, 0.61) and those in non-health related occupations (OR 0.78, CI 0.62, 0.97).ConclusionsPrevalence of overweight and obesity among Scottish nurses is worryingly high, and significantly higher than those in other healthcare professionals and non-health related occupations. High prevalence of overweight and obesity potentially harms nurses’ own health and hampers the effectiveness of nurses’ health promotion role. Interventions are therefore urgently required to address overweight and obesity among the Scottish nursing workforce.  相似文献   
10.
BackgroundHepatic Golgi protein-73 (GP73) expression is related to hepatocellular carcinoma (HCC) progression. The aim of this study was to investigate the dynamic expression of GP73 mRNA and protein during hepatocytes malignant transformation.MethodsHuman GP73 expressions in 88 HCC tissues and their self-control surrounding tissues were examined by immunohistochemistry, and survival time of HCC patients was evaluated by the Kaplan-Meier method. HCC model of Sprague-Dawley rats was made by diet containing 2-fluorenylacetamide. The rats were divided into the control, hepatocyte degeneration, precanceration, and HCC groups to observe GP73 protein and mRNA alterations during hepatocytes malignant transformation.ResultsThe GP73 expression was significantly higher in the cancerous tissues than that in the surrounding tissues, with shorter survival time, and the positive rates of GP73 protein in human HCC tissues were 53.3% at stage I, 84.0% at stage II, 84.6% at stage III, and 60.0% at stage IV, respectively. The positive rates of hepatic GP73 protein and mRNA in the rat models were none in the control group, 66.7% and 44.4% in the hepatocytes degeneration group, 88.9% and 77.8% in the hepatocytes precanceration group, and 100% in the HCC group, respectively. There was a positive correlation (r = 0.91, P<0.01) between hepatic GP73 and serum GP73 during rat hepatocytes malignant transformation.ConclusionsAbnormal GP73 expression may be a sensitive and valuable biomarker in hepatocarcinogensis.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号